LENSAR, Inc. (LNSR) Stock Analysis

Company Overview

LENSAR, Inc. (LNSR) is capitalised at $105.41M on the latest close. The company sits in the Healthcare sector, in the Medical Devices industry. The company reports 150 employees.

Over the past 52 weeks the price has ranged from $4.95 to $12.94. The most recent close on file for LNSR is $8.58, dated September 4, 2026. That is +$0.33 (+4.00%) against the previous close. The latest close sits 73.33% above that 52-week low.

Financial Health

Fiscal 2025 revenue came to $58.44M. That is +9.24% against the prior fiscal year, when revenue was $53.49M. The same year closed with a net loss of $34.28M. Profit margin runs at 57.57%. That is 59.3 percentage points above the Medical Devices median of −1.69%. Earnings per share on a trailing basis come to 0.2.

Across the 4 fiscal years on file, revenue moves from $35.36M in 2022 to $58.44M in 2025. Of those 4 years, 0 report positive net income.

Valuation Assessment

On trailing earnings, the shares are priced at 42.9 times earnings. That is 60.07% above the Medical Devices median of 26.8. The price-to-sales ratio is 1.75. On price-to-sales that is 41.23% below the Medical Devices median of 2.98. The medians here are taken across 151 Medical Devices companies that report the metric.

The trailing one-year price return is −29.50%. Across 5 years the annualized return works out at +0.86%. Beta against the wider market is reported at 0.97. Annualized volatility over the trailing 5 years is 65.82%.

Growth & Income

No dividend is on file for LNSR.

Across the complete calendar years on file, 2024 returned +154.70% and 2022 returned −50.58%. Of the 5 complete calendar years on file, 3 finished higher. So far in 2026 the price is −26.23%.